HERON THERAPEUTICS, INC. /DE/ (HRTX) Operating margin 2016–2025
HERON THERAPEUTICS, INC. /DE/ (HRTX) operating margin by fiscal year — reported operating income divided by reported revenue.
-1.6%FY2025 · since FY2016: -13363.2% → -1.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1.6% | +6.4 pp |
| FY2024 | -8.0% | +79.1 pp |
| FY2023 | -87.1% | +75.1 pp |
| FY2022 | -162.2% | +90.1 pp |
| FY2021 | -252.3% | +5.1 pp |
| FY2020 | -257.4% | -113.1 pp |
| FY2019 | -144.3% | +93.1 pp |
| FY2018 | -237.4% | +394.9 pp |
| FY2017 | -632.4% | +12730.8 pp |
| FY2016 | -13363.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice